Naoki Isogawa

5PUBLICATIONS
5CO-AUTHORS
Health and ecological risk assessmentClinimetricsCancer therapy (excl. chemotherapy and radiation therapy)Stochastic analysis and modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 10, 2024
Correction to: Performance Evaluation of Interim Analysis in Bioequivalence Studies : Naoki Isogawa.

Naoki Isogawa, Andy Grieve, Ryota Ishii

|May 24, 2024
Performance Evaluation of Interim Analysis in Bioequivalence Studies.

Naoki Isogawa, Andy Grieve, Ryota Ishii

|Nov 17, 2021
Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase III safety study.

Shin-Ichi Konno, Takuya Nikaido, John D Markman

|Dec 10, 2020
A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints.

Naoki Isogawa, Kentaro Takeda, Kazushi Maruo

|Aug 02, 2019
A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints.

Naoki Isogawa, Kentaro Takeda, Kazushi Maruo

Pageof 1

Frequent Collaborators

1 joint publications

Shin-Ichi Konno

1 joint publications

Takuya Nikaido

1 joint publications

John D Markman

1 joint publications

Lars Viktrup